Centessa Pharmaceuticals plc American Depositary Shares (CNTA)
PHARMACEUTICAL PREPARATIONS
- Headquarters
- United States
- Employees
- 129
- Market Cap
- $6.3B
About Centessa Pharmaceuticals plc American Depositary Shares
Centessa Pharmaceuticals PLC is a clinical-stage biotechnology company pioneering a new class of therapeutics in orexin-based neuroscience. The group is developing a franchise of small molecule orexin receptor 2 (OX2R) agonists designed to address neuroscience diseases underpinned by dysregulation of wakefulness, attention, cognition, mood, and other symptoms, each grounded in the shared biology of the orexin pathway. The company's programs and Pipeline are the Orexin Receptor 2 Agonist Program and LockBody Technology Platform.
SentiSense also tracks daily options readings for Centessa Pharmaceuticals plc American Depositary Shares: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Centessa Pharmaceuticals plc American Depositary Shares stock analysis, sentiment tracking, and market intelligence on SentiSense.